Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: A prospective fMRI study

Brain Imaging and Behavior

Volumn 7, Issue 4, 2013, Pages 460-477

  López Zunini, Rocío A ^a   Scherling, Carole ^a,c   Wallis, Nancy ^a   Collins, Barbara ^a,b   MacKenzie, Joyce ^b   Bielajew, Catherine ^a   Smith, Andra M ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Chemotherapy; Cognition; fMRI; Memory; Verbal recall

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL;

ADULT; ANTERIOR CINGULATE; ANXIETY; ARTICLE; BRAIN REGION; BREAST CANCER; CANCER PATIENT; CANCER SURVIVOR; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; FATIGUE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INSULA; MEMORY CONSOLIDATION; MIDDLE TEMPORAL GYRUS; MULTIPLE CYCLE TREATMENT; ORBITAL CORTEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECALL; SUPERIOR TEMPORAL GYRUS; VERBAL MEMORY;

ADULT; ANTINEOPLASTIC AGENTS; BRAIN; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MEMORY, SHORT-TERM; MIDDLE AGED; NERVE NET; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VERBAL LEARNING;

EID: 84901325918     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-012-9213-0     Document Type: Article

References (85)

1. Abraham, J., Haut, M. W., Moran, M. T., Filburn, S., Lemiuex, S., & Kuwabara, H. (2008). Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging. Clinical Breast Cancer, 8(1), 88-91. doi:10.3816/CBC.2008.n.007.
2. Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., et al. (2002). Neuropsychologic impact of standarddose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20(2), 485-493.
3. Alexander, M. P., Stuss, D. T., Picton, T., Shallice, T., & Gillingham, S. (2007). Regional frontal injuries cause distinct impairments in cognitive control. Neurology, 68(18), 1515-1523. doi:10.1212/ 01.wnl.0000261482.99569.fb.
4. Ando-Tanabe, N., Iwamitsu, Y., Kuranami, M., Okazaki, S., Yasuda, H., Nakatani, Y. et al. (2012). Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls. Breast Cancer. doi:10.1007/s12282-012-0405-7
5. Beck, A. T., & Steer, R. A. (1990). Beck Anxiety Inventory Manual. San Antonio Psychological Corporation.
6. Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck Depression Inventory (Secondth ed.). San Antonio: Psychological Corporation.
7. Bench, C. J., Frith, C. D., Grasby, P. M., Friston, K. J., Paulesu, E., Frackowiak, R. S., et al. (1993). Investigations of the functional anatomy of attention using the Stroop test. Neuropsychologia, 31 (9), 907-922.
8. Benoy, I. H., Salgado, R., Van Dam, P., Geboers, K., Van Marck, E., Scharpe, S., et al. (2004). Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clinical Cancer Research, 10 (21), 7157-7162. doi:10.1158/1078-0432.CCR-04-0812.
9. Biegler, K. A., Chaoul, M. A., & Cohen, L. (2009). Cancer, cognitive impairment, and meditation. Acta Oncologica, 48(1), 18-26. doi:10.1080/02841860802415535.
10. Bishop, S., Duncan, J., Brett, M., & Lawrence, A. D. (2004). Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli. Nature Neuroscience, 7(2), 184-188. doi:10.1038/nn1173.
11. Braslis, K. G., Santa-Cruz, C., Brickman, A. L., & Soloway, M. S. (1995). Quality of life 12 months after radical prostatectomy. British Journal of Urology, 75(1), 48-53.
12. Bremner, J. D. (2002). Structural changes in the brain in depression and relationship to symptom recurrence. CNS Spectrums, 7(2), 129-130, 135-129.
13. Brezden, C. B., Phillips, K. A., Abdolell, M., Bunston, T., & Tannock, I. F. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology, 18(14), 2695-2701.
14. Buckner, R. L., Raichle, M. E., Miezin, F. M., & Petersen, S. E. (1996). Functional anatomic studies of memory retrieval for auditory words and visual pictures. Journal of Neuroscience, 16(19), 6219-6235.
15. Buckner, R. L., Koutstaal, W., Schacter, D. L., Wagner, A. D., & Rosen, B. R. (1998). Functional-anatomic study of episodic retrieval using fMRI. I. Retrieval effort versus retrieval success. NeuroImage, 7(3), 151-162. doi:10.1006/nimg.1998.0327.
16. Burgess, C., Cornelius, V., Love, S., Graham, J., Richards, M., & Ramirez, A. (2005). Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ, 330 (7493), 702. doi:10.1136/bmj.38343.670868.D3.
17. Chen, Z., Malhotra, P. S., Thomas, G. R., Ondrey, F. G., Duffey, D. C., Smith, C. W., et al. (1999). Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clinical Cancer Research, 5(6), 1369-1379.
18. Cimprich, B., Reuter-Lorenz, P., Nelson, J., Clark, P. M., Therrien, B., Normolle, D., et al. (2010). Prechemotherapy alterations in brain function in women with breast cancer. Journal of Clinical and Experimental Neuropsychology, 32(3), 324-331. doi:10.1080/ 13803390903032537.
19. Collins, B., Mackenzie, J., Tasca, G. A., Scherling, C., & Smith, A. (2012). Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. Psychooncology, doi:10.1002/pon.3163.
20. Cook, D. B., O'Connor, P. J., Lange, G., & Steffener, J. (2007). Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls. NeuroImage, 36(1), 108-122. doi:10.1016/j.neuroimage.2007.02.033.
21. Damasio, H., Tranel, D., Grabowski, T., Adolphs, R., & Damasio, A. (2004). Neural systems behind word and concept retrieval. Cognition, 92(1-2), 179-229. doi:10.1016/j.cognition.2002.07.001.
22. de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., Caan, M., Douaud, G., et al. (2011a). Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Human Brain Mapping, doi:10.1002/hbm.21422.
23. de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., van Dam, F. S., Nederveen, A. J., et al. (2011). Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping, 32(8), 1206-1219. doi:10.1002/ hbm.21102.
24. Deckersbach, T., Dougherty, D. D., & Rauch, S. L. (2006). Functional imaging of mood and anxiety disorders. Journal of Neuroimaging, 16(1), 1-10. doi:10.1177/1051228405001474.
25. Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Van den Stock, J., et al. (2011). Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Human Brain Mapping, 32(3), 480-493. doi:10.1002/hbm.21033.
26. Deprez, S., Amant, F., Smeets, A., Peeters, R., Leemans, A., Van Hecke, W., et al. (2012). Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. Journal of Clinical Oncology, 30 (3), 274-281. doi:10.1200/JCO.2011.36.8571.
27. Devinsky, O., Morrell, M. J., & Vogt, B. A. (1995). Contributions of anterior cingulate cortex to behaviour. Brain, 118(1), 279-306.
28. Duarte, A., Henson, R. N., Knight, R. T., Emery, T., & Graham, K. S. (2010). The orbitofrontal cortex is necessary for temporal context memory. Journal of Cognitive Neuroscience, 22(8), 1819-1831. doi:10.1162/jocn.2009.21316.
29. Eichenbaum, H. (2000). A cortical-hippocampal system for declarative memory. Nature Reviews Neuroscience, 1(1), 41-50. doi:10.1038/ 35036213.
30. Engels, A. S., Heller, W., Spielberg, J. M., Warren, S. L., Sutton, B. P., Banich, M. T., et al. (2010). Co-occurring anxiety influences patterns of brain activity in depression. Cognitive, Affective, & Behavioral Neuroscience, 10(1), 141-156. doi:10.3758/CABN.10.1.141.
31. Femenia, T., Gomez-Galan, M., Lindskog, M., & Magara, S. (2012). Dysfunctional hippocampal activity affects emotion and cognition in mood disorders. Brain Research, doi:10.1016/j.brainres.2012.03.053.
32. Ferguson, R. J., McDonald, B. C., Saykin, A. J., & Ahles, T. A. (2007). Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. Journal of Clinical Oncology, 25(25), 3866-3870. doi:10.1200/JCO.2007.10.8639.
33. Francis, W. N., & Kucera, H. (1982). Frequency Analysis of English Usage. Boston: Houghton Mifflin.
34. Frick, E., Tyroller, M., & Panzer, M. (2007). Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: a cross-sectional study in a community hospital outpatient centre. European Journal of Cancer Care, 16(2), 130-136. doi:10.1111/ j.1365-2354.2006.00720.x.
35. Friston, K. J., Ashburner, J., Poline, J. B., Frith, C. D., Heather, J. D., & Frackowiak, R. S. J. (1995). Spatial realignment and normalization of images. Human Brain Mapping, 2, 165-189.
36. Gass, C. S., & Curiel, R. E. (2011). Test anxiety in relation to measures of cognitive and intellectual functioning. Archives of Clinical Neuropsychology, 26(5), 396-404. doi:10.1093/arclin/acr034.
37. Goodwin, J. M. (1997). Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. Journal of Psychopharmacology, 11(2), 115-122.
38. Greicius, M. D., Krasnow, B., Boyett-Anderson, J. M., Eliez, S., Schatzberg, A. F., Reiss, A. L., et al. (2003). Regional analysis of hippocampal activation during memory encoding and retrieval: fMRI study. Hippocampus, 13(1), 164-174. doi:10.1002/ hipo.10064.
39. Griffith, H. R., Richardson, E., Pyzalski, R. W., Bell, B., Dow, C., Hermann, B. P., et al. (2006). Memory for famous faces and the temporal pole: functional imaging findings in temporal lobe epilepsy. Epilepsy & Behavior, 9(1), 173-180. doi:10.1016/ j.yebeh.2006.04.024.
40. Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., et al. (2007). Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer, 109(9), 1905-1913. doi:10.1002/cncr.22610.
41. Huijbers, W., Pennartz, C. M., & Daselaar, S. M. (2010). Dissociating the "retrieval success" regions of the brain: effects of retrieval delay. Neuropsychologia, 48(2), 491-497. doi:10.1016/ j.neuropsychologia.2009.10.006.
42. Humphreys, M. S., & Revelle, W. (1984). Personality, motivation, and performance: a theory of the relationship between individual differences and information processing. Psychological Review, 91(2), 153-184.
43. Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., et al. (2007). Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer, 109(1), 146-156. doi:10.1002/ cncr.22368.
44. Jenkins, V., Shilling, V., Deutsch, G., Bloomfield, D., Morris, R., Allan, S., et al. (2006). A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer, 94(6), 828-834. doi:10.1038/sj.bjc.6603029.
45. Kesler, S. R., Bennett, F. C., Mahaffey, M. L., & Spiegel, D. (2009). Regional brain activation during verbal declarative memory in metastatic breast cancer. Clinical Cancer Research, 15(21), 6665-6673. doi:10.1158/1078-0432.CCR-09-1227.
46. Lachman, M. E., & Agrigoroaei, S. (2012). Low perceived control as a risk factor for episodic memory: the mediational role of anxiety and task interference. Memory and Cognition, 40(2), 287-296. doi:10.3758/s13421-011-0140-x.
47. Larson, S. J., & Dunn, A. J. (2001). Behavioral effects of cytokines. Brain, Behavior, and Immunity, 15(4), 371-387. doi:10.1006/ brbi.2001.0643.
48. Lorist, M. M., Boksem, M. A., & Ridderinkhof, K. R. (2005). Impaired cognitive control and reduced cingulate activity during mental fatigue. Brain Research. Cognitive Brain Research, 24(2), 199-205. doi:10.1016/j.cogbrainres.2005.01.018.
49. Lorr, M., McNair, D. M., Heuchert, J. W. P., & Droppleman, L. F. (2003). Profile of Mood States (POMS).
50. Manes, F., Springer, J., Jorge, R., & Robinson, R. G. (1999). Verbal memory impairment after left insular cortex infarction. Journal of Neurology, Neurosurgery, and Psychiatry, 67(4), 532-534.
51. McClintock, S. M., Husain, M. M., Greer, T. L., & Cullum, C. M. (2010). Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. Neuropsychology, 24(1), 9-34. doi:10.1037/a0017336.
52. McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Research and Treatment, 123(3), 819-828. doi:10.1007/s10549-010-1088-4.
53. McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2012). Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. Journal of Clinical Oncology, 30(20), 2500-2508. doi:10.1200/ JCO.2011.38.5674.
54. McDonald, B. C., Conroy, S. K., Smith, D. J., West, J. D., & Saykin, A. J. (2012b). Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study. Brain, Behavior, and Immunity, doi:10.1016/j.bbi.2012.05.007.
55. Mehlsen, M., Pedersen, A., Jensen, A., & Zachariae, R. (2009). No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psycho-Oncology, 18, 248-257. doi:10.1002/pon.1398.
56. Menon, V., Boyett-Anderson, J. M., Schatzberg, A. F., & Reiss, A. L. (2002). Relating semantic and episodic memory systems. Brain Research, 13(2), 261-265.
57. Meyers, C. A., Albitar, M., & Estey, E. (2005). Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer, 104(4), 788-793. doi:10.1002/cncr.21234.
58. Mitchell, S. A. (2010). Cancer-related fatigue: state of the science. PM & R, 2(5), 364-383. doi:10.1016/j.pmrj.2010.03.024.
59. Monk, T. G., Weldon, B. C., Garvan, C. W., Dede, D. E., van der Aa, M. T., Heilman, K. M., et al. (2008). Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology, 108 (1), 18-30. doi:10.1097/01.anes.0000296071.19434.1e.
60. Nyberg, L., McIntosh, A. R., Houle, S., Nilsson, L. G., & Tulving, E. (1996). Activation of medial temporal structures during episodic memory retrieval. Nature, 380(6576), 715-717. doi:10.1038/ 380715a0.
61. Oldridge, N., Streiner, D., Hoffmann, R., & Guyatt, G. (1995). Profile of mood states and cardiac rehabilitation after acute myocardial infarction. Medicine and Science in Sports and Exercise, 27(6), 900-905.
62. Rushworth, M. F., Hadland, K. A., Paus, T., & Sipila, P. K. (2002). Role of the human medial frontal cortex in task switching: a combined fMRI and TMS study. Journal of Neurophysiology, 87(5), 2577-2592.
63. Rutkowski, P., Kaminska, J., Kowalska, M., Ruka, W., & Steffen, J. (2003). Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis. Journal of Surgical Oncology, 84(3), 151-159. doi:10.1002/jso.10305.
64. Saykin, A. J., Gur, R. C., Sussman, N.M., O'Connor, M. J., &Gur, R.E. (1989). Memory deficits before and after temporal lobectomy: effect of laterality and age of onset. Brain and Cognition, 9(2), 191-200.
65. Saykin, A. J., Ahles, T. A., & McDonald, B. C. (2003). Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Seminars in Clinical Neuropsychiatry, 8(4), 201-216.
66. Saykin, A. J., McDonald, B. C., Ahles, T., Chesnut, L. A., Wang, P. J., Furstenberg, C. T., et al. (2006). Altered brain activation following systemic chemotherapy for breast cancer: interim analysis from a prospective fMRI study In 34th Annual Meeting of the International Neuropsychological Society, Boston.
67. Schag, C. A., Ganz, P. A., Kahn, B., & Petersen, L. (1992). Assessing the needs and quality of life of patients with HIV infection: development of the HIV Overview of Problems-Evaluation System (HOPES). Quality of Life Research, 1(6), 397-413.
68. Schagen, S. B., van Dam, F. S., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer, 85(3), 640-650. doi:10.1002/(SICI)1097-0142.
69. Scherling, C., Collins, B., MacKenzie, J., Bielajew, C., & Smith, A. (2011). Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study. Frontiers in Human Neuroscience, 5(122), 1-21. doi:10.3389/fnhum.2011.00122.
70. Scherling, C., Collins, B., MacKenzie, J., Bielajew, C., & Smith, A. (2012a). Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging study. Journal of Clinical and Experimental Neuropsychology, 2-18, doi:10.1080/13803395.2012.666227.
71. Scherling, C., Collins, B., Mackenzie, J., Lepage, C., Bielajew, C., & Smith, A. (2012b). Structural brain differences in breast cancer patients compared to matched controls prior to chemotherapy. International Journal of Biology, 4(2), 3-25.
72. Schnider, A., Treyer, V., & Buck, A. (2000). Selection of currently relevant memories by the human posterior medial orbitofrontal cortex. Journal of Neuroscience, 20(15), 5880-5884.
73. Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008). Cytokines and their relationship to the symptoms and outcome of cancer. Nature Review Cancer, 8(11), 887-899. doi:10.1038/ nrc2507.
74. Servaes, P., Verhagen, C., & Bleijenberg, G. (2002). Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. European Journal of Cancer, 38(1), 27-43.
75. Shinoura, N., Midorikawa, A., Kurokawa, K., Onodera, T., Tsukada, M., Yamada, R., et al. (2011). Right temporal lobe plays a role in verbal memory. Neurology Research, 33(7), 734-738. doi:10.1179/1743132811Y.0000000005.
76. Silverman, D. H., Dy, C. J., Castellon, S. A., Lai, J., Pio, B. S., Abraham, L., et al. (2007). Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Research and Treatment, 103(3), 303-311. doi:10.1007/s10549-006-9380-z.
77. Spichiger, E., Muller-Frohlich, C., Denhaerynck, K., Stoll, H., Hantikainen, V., & Dodd, M. (2011). Prevalence of symptoms, with a focus on fatigue, and changes of symptoms over three months in outpatients receiving cancer chemotherapy. Swiss Medical Weekly, 141, 1-11. doi:10.4414/smw.2011.13303.
78. Tchen, N., Juffs, H. G., Downie, F. P., Yi, Q. L., Hu, H., Chemerynsky, I., et al. (2003). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology, 21(22), 4175-4183. doi:10.1200/JCO.2003.01.119.
79. Toglia, M. P., & Battig, W. F. (1978). Handbook of Semantic Word Norms. Hillsdale: Erlbaum.
80. van Dam, F. S., Schagen, S. B., Muller, M. J., Boogerd, W., vd Wall, E., Droogleever Fortuyn, M. E., et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. Journal of the National Cancer Institute, 90 (3), 210-218.
81. Vardy, J., Booth, C., Pond, G. R., Zhang, H., Galica, J., Dhillon, H., et al. (2007). Cytokine levels in patients with colorectal cancer and breast cancer and their relationship to fatigue and cognitive function. Paper presented at the The American Society of Clinical Oncology, Chicago, IL.
82. Wechsler, D. (1997). Wechsler Adult Intelligence Scale (3rd ed.). San Antonio: Harcourt, Brace & Co.
83. Wefel, J. S., Lenzi, R., Theriault, R., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004). 'Chemobrain' in Breast Carcinoma? Cancer, 101(3), 466-475. doi:10.1002/cncr.20393.
84. Wieneke, M. H., & Dienst, E. R. (1995). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology, 4, 61-66.
85. Zachariae, R., & Mehlsen, M. Y. (2011). Is chemotherapy associated with cognitive impairment? Nature Reviews, 8(4), 182-183. doi:10.1038/nrurol.2011.29.